Efficacy and tolerability of a fixed-dose moxifloxacin – dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial

PURPOSE: To compare the efficacy and tolerability of a fixed-dose combination of 0.5% moxifloxacin and 0.1% dexamethasone formulation (MFLX/DEX) vs conventional dosing with both agents dosed separately for prophylaxis after laser-assisted in situ keratomileusis (LASIK). METHODS: A prospective, rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Mauro, Ávila, Mariana, Wallau, Anelise, Muccioli, Cristina, Höfling-Lima, Ana Luisa, Belfort, Rubens
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693985/
https://www.ncbi.nlm.nih.gov/pubmed/19668724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693985/
https://www.ncbi.nlm.nih.gov/pubmed/19668724

Ejemplares similares